Nearly 6 years have passed since the Needlestick Safety and Prevention Act of 2000 was signed into law. We reviewed studies published since 1995 that evaluated the effect of safety-engineered device implementation on rates of percutaneous injury (PI) among health care workers. Criteria for inclusion of studies in the review were as follows: the intervention used to reduce PIs was a needleless system or a device with engineered sharps-injury protection, the outcome measurements included a PI rate, the intervention was evaluated in a defined population with clear comparison groups in clinical settings, and outcomes and denominators used for rate calculations were objectively measured using consistent methodology. All 17 studies reported substantial decreases in device-associated or overall PI rates after device implementation (range of reduction, 22%-100%). The majority of studies ( ) were uncontrolled before-after trials with limited ability to control for confounding n p 12 variables. In addition, implementation of safety-engineered devices was often accompanied by other interventions, and direct measurement of outcomes was not performed. Nevertheless, safety-engineered devices are an important component in PI prevention.
. Study selection. *One erratum and 1 request for information; + , findings published elsewhere (2 eliminated references) or eliminated due to potential investigator bias. HCWs, health care workers; PIs, percutaneous injuries.
truncation. Additional references from the bibliographies of articles included in the search and relevant review articles were appraised. The subsequent search yielded 2045 nonduplicate English-language references. In addition, the Internet was searched for regulatory and legislative documents.
Study selection. Our objective was to examine studies that evaluated the effect of device implementation (specifically, devices mandated by the Needlestick Safety and Prevention Act) on the rate of PIs among HCWs. Therefore, our first 2 inclusion criteria were introduction of an engineered sharps-injury protection device or needleless system (criterion A) and measurement of a PI rate among HCWs (criterion B). Although all study designs were considered to be eligible for inclusion, we used 2 criteria regarding methodology: the intervention was evaluated in a defined population with clear comparison groups in clinical settings (criterion C), and outcomes and denominators were objectively measured using consistent methods over the duration of the study (criterion D). Two additional studies in which only investigators used intervention devices were not included in the review.
All articles were initially screened by one investigator (S.T.). Nonresearch reports, non-primary research articles, letters, and case reports or studies were excluded from the review (n p ). During subsequent detailed review, relevant data were 1043 abstracted by one investigator (S.T.) using standardized forms, with guidance provided by another investigator (K.A.S.). Final decisions regarding study inclusion were made by consensus. A total of 17 studies that met the aforementioned criteria are presented here (figure 1). Table 1 provides a summary of study characteristics for the 17 articles included in this review [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . There was variability in the total duration of the studies (range, 6 months to 9 years). The majority occurred in the United States in health care institutions with varying levels of care. Two multicenter studies were included in the review [7, 16] .
RESULTS

Study characteristics.
The most commonly evaluated safety-engineered devices were needleless intravenous systems (evaluated in 8 of 17 studies) [5, 6, 11, [14] [15] [16] [17] 19] , followed by safety syringes [4, 5, 11, 12, 19] , resheathable winged steel needles [3, 5, 7, 8] , vacuumtube blood-collection devices [3, 5, 7] , retractable lancets [4, 10] , and guarded arteriovenous fistula needles [9] . Eight studies evaluated the introduction of 11 type of device. Five studies specified the inclusion of additional nondevice interventions during implementation, including use of new waste disposal bins [12] , education about needle recapping [13] , training related to exposure prevention [4, 6] , and a multifocal approach incorporating administrative and work practice controls [14] .
Some investigators assessed the effects of implementation of multiple devices on overall PI rates [4-6, 11, 13, 14] and/or parsed the effects of a particular device by calculating deviceor procedure-associated injury rates [3, 5-10, 12, 14-17] . Devices were often introduced across relatively large areas (institution-wide or across several units); therefore, sample sizes of most studies were relatively robust, although the number of HCWs involved varied. Investigators reported the annual average numbers of full-time-equivalent (FTE) HCWs (range, 1167-8500) [3-6, 11, 14, 16] , procedures or devices during each study period (range, ∼6500 to 2.5 million) [3, [7] [8] [9] 18] , and/or HCWs who participated in the studies (range, 78-477) [9, 10, 12, 18] .
Denominators. Most study populations included all HCWs at risk for PI [3, 5-10, 15, 18] . Subsets of HCWs were examined primarily when accurate denominators were unavailable for certain occupational groups. For calculation of PI rates, most studies applied measures of person-time at risk, including FTE HCWs [4, 5, 11, 14, 16] , HCW-days [19] , person/worker-years [6, 10] , and hours/productive hours worked [12, 17] . To adjust for differences in device utilization, studies also calculated PI rates using numbers of patient-days [17] and occupied hospital beds [6] .
In 4 studies, the estimated number of procedures performed served as the denominator. These estimates were determined via reviews of randomly sampled medical charts [18] , anonymous HCW surveys [7] , or information on the number of devices purchased [3] . One study did not specify how the number of devices used was determined [9] . Two studies circumvented such estimation by calculating rates using the number of devices purchased [8, 13] .
Measurement of outcome events. The scope of safety-engineered device implementation rendered direct measurement of PIs impossible. This necessitated use of formally reported PIs for calculations of the injury rate. Changes in reporting rates over time can introduce bias to estimates of the effectiveness of interventions. Several investigators discussed the possibility that increased reporting could occur during studies as a result of heightened HCW awareness, thereby biasing device effectiveness toward the null. In one study, amendment of the PI reporting procedure was a component of the multifocal intervention [14] . However, the influence of this particular intervention on overall study outcome was not accounted for.
Two studies assessed PI reporting rates both before and after device implementation. HCWs anonymously recalled the number of injuries that were sustained and formally reported during the previous 12 months. Alvarado-Ramy et al. [7] noted that, within occupational groups, reporting rates were similar among hospitals and between surveys (54%). Sohn et al. [5] cited a concurrent study [21] that found stable overall PI reporting rates from the preintervention to postintervention periods (22.8%-21.9%; P value, not statistically significant [NS] ). The potential for recall bias was acknowledged, although one group of investigators posited no discernible reason for more bias to be present during one study period versus the other [21] . Varying rates of PI reporting across hospitals and HCW occupational groups complicate interinstitutional comparison of injury rates.
Two studies examined the effects of new devices on patientassociated outcomes. Mendelson et al. [15] found no significant differences in either the objective signs of phlebitis or the mortality rate between control and intervention groups. In addition, no statistically significant differences in device-associated bacteremia or bacteremia due to an unknown source were found, although sample sizes were small. O'Connor et al. [18] noted that the rate of successfully placed intravenous catheters did not change after conversion to a self-sheathing catheter.
Assessment of reduction in PI rates. All studies reported decreases in device-associated or overall PI rates after implementation of safety-engineered devices (range of reduction, 9.8%-100%). Several authors reported study design and performance issues that may have affected demonstration of attributable benefit.
Twelve studies used uncontrolled before-after trial designs. Implementation was institution-wide, and observed changes in PI rates were attributed to the intervention(s). In comparisons of preintervention and postintervention PI rates, more than half of these studies [4, 6, 7, 9-11, 18, 19] did not exclude data from an "implementation" or "training" period (range of duration, 1 month to 1 year) during which HCWs became familiar with new devices.
Four of the 12 studies provided information on separate outcome markers that were not expected to decrease with use of a new device. Rogues et al. [3] noted that, although rates of phlebotomy-associated PIs declined dramatically, rates of non-phlebotomy-associated PIs did not significantly decrease. Sohn et al. [5] documented a 70.6% decrease in rates of hollowbore needle-associated PI ( ); rates of PI associated with P ! .001 suture needles and "other sharp objects" also decreased, albeit to a lesser degree (30.8% and 13.8%, respectively; , for P p NS both). Gershon et al. [14] noted rate reductions across a range of injury categories not specifically targeted by the safer devices, although rates of solid needle-associated PIs increased slightly ( ) . P p NS After a needleless intravenous system was implemented at 2 hospitals, Lawrence et al. [16] observed statistically significant NOTE. AVFN, arteriovenous fistula needle; BBFE, blood body-fluid exposure; BBP, bloodborne pathogen; EMS, emergency medical service; FTE, full-time equivalent; HCW, health care worker; ICU, intensive care unit; iv, intravenous; IVCR, intravenous connection related; MBC, metal blunt cannula; NA, not available; NS, not significant; OSHA, Occupational Safety and Health Organization; PBC, plastic blunt cannula; PI, percutaneous injury; preint., preintervention; RR, rate ratio; VTBCD, vacuum-tube blood-collection device.
a The PI rate for the preint. period was available for 1 year only. b Reduction in phlebotomy-related device-associated PI rate. c Incidence rate ratios and respective 95% CIs were calculated [20] . d All data are not shown for residents. e Maintenance, laundry, and kitchen employees. f Select data for the 31-month poststudy period were presented; authors considered this phase to be separate from the before-after trial. g One-sided P value. h Used unsheathed needles that were discovered when needles were returned for autoclaving. i Because of compatibility, accessibility and other technical issues related to the device. j RR per 1000 patient-days, 0.11 (95% CI, 0.01-0.92; ); RR per 1000 productive hours worked, 0.08 (95% CI, 0.01-0.69; ). P p .03 P p .005 k HCW dissatisfaction with study devices resulted in use of conventional devices still available in intervention areas. System incompatibilities led to unsafe device manipulations; stressed need for concurrent HCW education about behavioral compliance.
reductions (62.4% and 70.2%) in rates of intravenous connection-related PIs. Significant decreases in rates of PIs not related to intravenous connections were also observed (17.5% and 30.4%, respectively). The investigators calculated adjusted rates of intravenous connection-related PIs to account for reductions not attributable to the new devices (54.5% and 57.2%, respectively;
). P р .005 Zakrzewska et al. [12] found that all avoidable syringe-related injuries occurred within 6 months after implementation, with no subsequent PIs reported in intervention areas during the remaining 18 months of the study. These PIs were deemed to be associated with a lack of training. The investigators cited measures to promote education about device use, such as formal testing of all students. The self-selected control unit, who decided against adoption of safety devices, also experienced decreases in syringe-related injuries, although to a lesser extent (100% vs. 25%). Of note, used unsheathed needles that were discovered upon return for autoclaving (known as "near misses") were included in injury counts during the postintervention period. Whether this category was examined before implementation was unclear.
Two randomized, controlled trials examined introduction of safer devices in selected hospital areas [17, 19] . Both studies noted protocol compliance issues resulting from the availability of conventional devices in intervention units and the preference of HCWs. In the study by L'Ecuyer et al. [17] , dissatisfaction with the metal blunt cannula tubing system led to early termination of its evaluation. The plastic 2-way valve system, which replaced the metal blunt cannula, had comparably low user satisfaction. No significant differences in PI rates were observed for the metal blunt cannula and 2-way valve systems. However, the plastic blunt cannula system had high user-satisfaction ratings and demonstrated an ∼90% reduction in rates of intravenous therapy-associated PI ( ). The investi-P р .03 gators highlighted the need to focus attention on the removal of conventional devices prior to initiation of device-evaluation studies.
Orenstein et al. [19] found compliance rates of 50% with needleless intravenous components. Compliance with the other evaluated device was not assessed, although product evaluations revealed that fewer respondents supported its purchase, compared with purchase of the needleless system (73% vs. 94%). Although overall PI rates decreased by 61% ( ), no sig-P ! .05 nificant differences in device-associated or total PI rates were observed between control and intervention units. Investigators cited insufficient power and low compliance as possible factors for the apparent lack of benefit attributable to protective devices.
Factors affecting the impact of devices. Investigators discussed several factors that could affect the influence of safetyengineered devices on PI rates. These factors included whether HCWs were involved in device selection, the acceptance of safety devices by HCWs, the rates of safety mechanism engagement, and the availability and use of conventional devices in intervention areas (table 2) . Three studies explicitly stated that frontline HCWs participated in the selection of safetyengineered devices [5, 7, 12] . By use of cross-sectional anonymous surveys, 5 studies assessed HCW satisfaction with the safety devices [7, 8, 16, 17, 19] . Satisfaction was often dependent on the compatibility of the devices with existing equipment and/or the ease of use. PI reports that documented conventional devices as a cause of injury alerted some investigators to the continued availability of such devices [11, 16, 17] . Rates of safety mechanism activation and/or the availability of conventional devices were determined by audits of sharps containers in 2 studies [7, 8] .
In one multicenter study of 3 safety devices [7] , the authors noted that results of implementation were dependent on 2 variables: compliance with device use and activation rates. Activation rates were correlated with ease of use, the device preferences of HCWs, and levels of individualized training. The reduction in PI rates associated with resheathable winged steel needles was 23% ( ). However, investigators noted that P p .07 18% of all winged steel needles found in audits of sharps containers were conventional devices and that the activation rate was only 56%. A different evaluation of the same product documented a 52.2% ( ) reduction in rates of device-as-P p .001 sociated PIs [8] . In this report, compliance was higher (only 5.4% of all winged steel needles were conventional devices), and the activation rate was 83%.
Safety of safety devices. Sohn et al. [5] noted that 27% of all postintervention PIs were caused by safety-engineered devices. Data were incomplete for nearly half these injuries, highlighting the importance of collecting sufficient data to identify problematic patterns. Available information indicated that these PIs resulted from improper activation or nonactivation of devices. It was suggested that more-intensive training efforts focusing on proper use and technique could further reduce injury rates. A concurrent study showed improvement in activation rates (from 63.5% to 87.5%) 6 months to 1 year after implementation [22] .
Mendelson et al. [8] found a slightly higher percentage of injuries due to improper activation or nonactivation of devices (36%) during the first posttest period. During the second posttest period, this percentage decreased to 26%, whereas the percentage of injuries that occurred before appropriate activation of the safety mechanism increased from 39% to 59% (P p , for both). This finding suggested that compliance and ac-NS ceptability can improve with increased use of a device.
Assessment of implementation costs. Five studies included information on costs associated with device implementation [10, 12, 13, 15, 19] . One study included estimates for indirect costs of personnel time for training and education [13] , and 2 studies considered productive work time lost [12, 13] ; no studies took into account the costs associated with transmission of bloodborne pathogens. Estimated costs associated with prophylaxis and HCW evaluations ranged from an average of $260 (in US dollars) in 1992 [19] to $5540 (in US dollars) in 2001 (under the assumptions that a full course of prophylaxis was received and sickness leave was taken) [12] . Roudot-Thoraval et al. [13] found that poor compliance with treatment guidelines resulted in actual management costs of only $325/injured HCW, whereas full compliance carried an estimated management cost of $1796/injured HCW. Three studies provided the estimated costs per PI prevented (range, $789-$4000) [13, 15, 19] . Orenstein et al. [13] noted that their average PI evaluation cost was lower than other published costs ($260 vs. a range of $300-$1200); application of these higher costs to their study findings would result in a savings of $141/PI prevented. Peate [10] calculated an annual savings of $5160 with implementation of self-retracting lancets among emergency medical system workers. The minimal annualized increase in equipment cost, exclusion of indirect costs, and training schedules that capitalized on lulls in the volume of emergency calls contributed to savings. Estimates of costeffectiveness per injury averted are dependent on respective PI management protocols, incremental cost of the safety device(s) implemented, personnel costs for training and education, and the additional indirect costs that are included.
Transmission of bloodborne pathogens. Four studies provided information on reported transmission of bloodborne pathogens to HCWs during the study periods. Roudot-Thoraval et al. [13] reported that 1 case of hepatitis C virus seroconversion occurred after implementation. No seroconversions were reported in the other 3 studies [3, 10, 19] .
DISCUSSION
It is estimated that ∼400,000 PIs occur annually among hospital-based HCWs in the United States [23] . This number does not include PIs sustained by HCWs in nonhospital settings, who comprise 60% of the health care labor force. The number of PIs is expected to increase due to the expansion of health care. In 2002, health care was the largest industry, with employment projected to increase 28% by 2012 [24] .
The risk of seroconversion following a percutaneous exposure to infected blood is ∼0.3% (95% CI, 0.2%-0.5%) for HIV [25, 26] , averages 1.8% (range, 0%-7%) for hepatitis C virus [27, 28] , and is 6%-30% for hepatitis B virus [29] . Recognition of risk resulted in the introduction of the Needlestick Safety and Prevention Act of 2000 [1] .
In all studies reviewed, introduction of safety-engineered devices was followed by considerable reductions in PI rates (range, 22%-100%). The majority of these reports, however, were uncontrolled before-after trials with inherent limitations to control for confounding variables. Implementation of safety-engineered devices was accompanied by HCW training and education efforts, and/or other interventions. Direct measurement of outcomes was not performed.
Blinded, randomized, controlled trials, which are considered the "gold standard," cannot be used to assess device implementation, because HCWs must be appropriately trained in device use. Randomization of individual HCWs is difficult in settings outside the operating room, as are direct observations of compliance with device use and PI events [30] . Quasi-experimental studies are often used when randomized trials are not feasible. These study-design options vary in their relative methodologic quality [31] .
External factors may also limit the choice of study design. Occupational Safety and Health Organization compliance requirements may constrain the use of conventional devices by control groups. The impetus to produce desired changes rapidly may preclude investigators from using methodologically stronger controlled or removed-treatment designs [32] . Significant changes would likely be facilitated by multiple interventions. Therefore, implementation of concurrent measures frequently occurs.
The statistically infrequent occurrence of recorded PIs requires that studies have large sample sizes (100,000 to 4.5 million of each device) to achieve adequate power for detection of significant differences [33] . Use of interventions by many HCWs over larger areas achieves needed sample sizes in a more timely fashion. However, inability to directly measure a number of PIs remains a universal study limitation. Whether changes in reporting bias occur over time is not known.
Appropriate devices also should not expose patients to adverse events. To date, a causal association between an increased risk of bloodstream infection and use of needleless systems has not been established when devices are used as recommended (according to manufacturers' directions, with rigorous aseptic technique) [34, 35] . However, potential risk factors for bloodstream infection with the use of needleless systems have been identified, including faulty device design, inadequate infectioncontrol practices, and user competency [34, 36, 37] .
Only 4 of 17 studies provided information on HIV, hepatitis C virus, or hepatitis B virus seroconversion in HCWs [3, 10, 13, 19] . We suggest the inclusion of these data in future studies.
In summary, all studies that were reviewed demonstrated decreases in PI rates after introduction of safety-engineered devices. These reductions occurred with the use of a variety of devices across a broad range of durations, hospital settings, and geographic locations. Introduction of innovative devices is an important component in the prevention of PIs, and its influence cannot be understated. Additional elements, however, are integral to achieving successful reductions in PI rates and pro-tecting patient safety. These measures include education of HCWs, participation of HCWs in device selection, adequate training in the appropriate use of devices, and continued collection and analysis of relevant surveillance data. A flood of new devices into the evolving market requires continued vigilance in evaluation and training efforts. Additional information is needed on related issues, including cost, the effect on rates of bloodstream infection, and impact on the rate of bloodborne pathogen transmission to HCWs.
